Hormonal
GLP-1 receptor agonists are associated with reduced risks of various psychiatric disorders, including substance use disorders, suicidal ideation, and dementia, suggesting potential neuroprotective benefits beyond weight management.
While GLP-1RAs are primarily used for weight loss, emerging large-scale data suggests they may also reduce the risk of certain psychiatric conditions like dementia and substance use disorders. However, these benefits are observational, and more research is needed to confirm if GLP-1RAs directly cause these improvements or if other factors are involved.
GLP-1RA use was linked to lower risks of substance-related disorders... reduced suicidal ideation, self-harm... and neurocognitive disorders... including dementia and Alzheimer’s disease.
Why this rating
Based on large observational databases (Xie et al.) and preclinical models, but lacks direct RCT evidence for psychiatric outcomes in SPMI.
Source
GLP-1 Receptor Agonists as a Novel Solution for Antipsychotic-Induced Weight Gain in Severe and Persistent Mental Illness
Samantha Jacobson et al. · The Canadian Journal of Psychiatry · 2025
DOI 10.1177/07067437251386626
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →